Innovation
Children affected by a fatal genetic disorder called Canavan disease are seeing their conditions improve with a first-of-its kind breakthrough treatment now in human clinical trials. The revolutionary gene therapy is based on a lifetime of research by Dr. Paola Leone at the Rowan University School of Osteopathic Medicine.
A diagnostic test for early-stage Alzheimer’s disease using just a drop of blood is possible, due to the work of Rowan University’s Dr. Robert Nagele. His team’s discovery that all people have thousands of autoantibodies that clear cell and tissue debris from their blood could lead to the early detection of many diseases, such as Parkinson’s disease, multiple sclerosis and breast cancer.
Physicians look at MRI images of the brain to spot the growth of tumors, but artificial intelligence technology developed by Dr. Nidhal Bouaynaya and her research partners now means a computer can detect and map changes as much as three years’ earlier than before. One day, that could revolutionize the diagnosis of brain tumors.